Xin Shi Selected Research

Deep Brain Stimulation

1/2022	The need to be alert to complications of peri-lead cerebral edema caused by deep brain stimulation implantation: A systematic literature review and meta-analysis study.
1/2021	Case Report: Bilateral Deep Brain Stimulation Implantation on Different Targets for a Parkinson's Disease Patient With a Bullet in the Brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin Shi Research Topics

Disease

46	Neoplasms (Cancer) 05/2024 - 05/2003
21	Osteosarcoma (Osteogenic Sarcoma) 02/2021 - 04/2006
16	Inflammation (Inflammations) 03/2024 - 04/2007
15	Infections 03/2024 - 10/2006
15	Neoplasm Metastasis (Metastasis) 11/2023 - 07/2003
11	Carcinogenesis 05/2024 - 10/2013
9	Wounds and Injuries (Trauma) 04/2023 - 02/2009
6	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2024 - 01/2021
6	Stomach Neoplasms (Stomach Cancer) 12/2023 - 08/2017
5	Necrosis 03/2024 - 10/2014
5	Hypoxia (Hypoxemia) 09/2023 - 02/2011
5	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 07/2003
5	Pancreatic Neoplasms (Pancreatic Cancer) 04/2021 - 01/2002
4	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 11/2014
4	Fibrosis (Cirrhosis) 02/2024 - 11/2007
4	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2023 - 06/2017
4	Bacteremia 01/2021 - 06/2013
4	Acute Necrotizing Pancreatitis 02/2013 - 01/2003
3	Sepsis (Septicemia) 03/2024 - 01/2023
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2019
3	Ischemia 10/2023 - 02/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2016
3	Pain (Aches) 01/2023 - 11/2007
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
3	Glioma (Gliomas) 08/2021 - 01/2021
3	Carcinoma (Carcinomatosis) 12/2019 - 01/2014
3	Breast Neoplasms (Breast Cancer) 01/2019 - 11/2015
3	Chronic Pancreatitis 11/2007 - 04/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 10/2017
2	Glaucoma 04/2024 - 02/2023
2	Pathologic Constriction (Stenosis) 04/2024 - 01/2022
2	Atherosclerosis 03/2024 - 11/2015
2	Melanoma (Melanoma, Malignant) 01/2024 - 01/2020
2	Brain Injuries (Brain Injury) 10/2023 - 02/2011
2	Stroke (Strokes) 09/2023 - 01/2021
2	Bacterial Infections (Bacterial Infection) 02/2023 - 12/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2023 - 03/2022
2	Carotid Artery Diseases 01/2023 - 11/2015
2	Scoliosis 01/2023 - 01/2022
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2021
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2023 - 01/2021
2	Cicatrix (Scar) 01/2023 - 08/2022
2	Atherosclerotic Plaque (Atheroma) 01/2023 - 11/2015
2	Burns 01/2023 - 01/2010
2	Urinary Tract Infections (Urinary Tract Infection) 06/2022 - 01/2020
2	Lung Injury 01/2022 - 07/2003
2	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 12/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

19	Messenger RNA (mRNA)IBA 03/2024 - 01/2002
19	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2003
12	Biomarkers (Surrogate Marker)IBA 04/2023 - 04/2006
12	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2013
11	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2005
10	Long Noncoding RNAIBA 09/2023 - 01/2019
8	Retinaldehyde (Retinal)IBA 02/2024 - 01/2019
5	CollagenIBA 05/2024 - 07/2014
5	EnzymesIBA 04/2024 - 04/2007
4	6-methyladenineIBA 03/2024 - 11/2020
4	Therapeutic UsesIBA 06/2023 - 10/2012
4	NucleotidesIBA 06/2022 - 10/2013
4	Indicators and Reagents (Reagents)IBA 12/2021 - 10/2015
4	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2021 - 10/2014
4	Small Interfering RNA (siRNA)IBA 06/2017 - 10/2015
4	Atrial Natriuretic Factor (ANF)IBA 02/2013 - 01/2003
4	Substance PIBA 11/2007 - 05/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 01/2022
3	Transcription Factors (Transcription Factor)IBA 01/2024 - 10/2017
3	Circular RNAIBA 11/2023 - 12/2022
3	Caspase 3 (Caspase-3)IBA 06/2023 - 12/2014
3	ChitosanIBA 02/2023 - 07/2014
3	InflammasomesIBA 01/2023 - 11/2015
3	LigandsIBA 08/2021 - 05/2003
3	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 01/2019 - 10/2017
3	NeuropeptidesIBA 11/2007 - 07/2003
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 07/2003 - 01/2003
2	ImmunosorbentsIBA 04/2024 - 11/2015
2	Phosphotransferases (Kinase)IBA 02/2024 - 01/2024
2	AdiponectinIBA 01/2024 - 01/2020
2	erucylphosphocholineIBA 01/2024 - 01/2023
2	Small Cytoplasmic RNAIBA 01/2024 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 01/2022
2	LipidsIBA 09/2023 - 01/2022
2	AcidsIBA 09/2023 - 02/2023
2	acylcarnitineIBA 09/2023 - 02/2016
2	Hematoxylin (Haematoxylon)IBA 01/2023 - 11/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 01/2021
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2023 - 12/2014
2	AlkaliesIBA 01/2023 - 07/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2023 - 11/2007
2	Competitive Endogenous RNAIBA 01/2023 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 08/2015

Therapy/Procedure

21	Therapeutics 04/2024 - 12/2010
7	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
4	Intravenous Injections 01/2024 - 06/2013
4	Immunotherapy 01/2024 - 01/2022
3	Ligation 03/2024 - 02/2011
2	Punctures 03/2024 - 01/2023
2	Nephrectomy 02/2024 - 01/2020
2	Deep Brain Stimulation 01/2022 - 01/2021
2	Aftercare (After-Treatment) 01/2022 - 04/2019